The Legislature finds that allowing the citizens of the State to import certain prescription drugs that are branded and registered in Canada, but unapproved by the United States Department of Health and Human Services, Food and Drug Administration in the Canadian branded or generic formula, will not present an unreasonable risk to individuals or public health and will result in a significant reduction in the cost of necessary drugs for consumers in the State.